✦ LIBER ✦

Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer

✍ Scribed by Anthony A. Rayner; Elizabeth A. Grimm; Michael T. Lotze; Elizabeth W. Chu; Steven A. Rosenberg

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 601 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850315)55:6<1327::aid-cncr2820550628>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T cell nature of some lymphokine-activat

T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells

✍ Lorenzo Moretta; Daniela Pende; Raffaella Cozzani; Annalisa Merli; Marcello Bagn 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

The cell lineage of the lymphokine-activated killer (LAK) cells has been reinvestigated. Both T and non-T cells, isolated on the basis of rosette formation with sheep erythrocytes (E), generated LAK activity after 3-4 days of culture in recombinant interleukin 2 (rIL 2) in 8 different individuals te

The requirements for successful immunoth

The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells

✍ Reyer T. Ottow; Alexander M. M. Eggermont; E. Philip Steller; Paul H. Sugarbaker 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

In a significant proportion of patients with gastrointestinal and ovarian malignancy the peritoneal cavity is a prominent site at which surgical treatment fails. Adjuvant treatments directed at this site should be investigated in an attempt to improve survival in patients with these cancers. In the

The relationship of clinical status and

The relationship of clinical status and therapeutic modality to natural killer cell activity in human breast cancer

✍ Bluma G. Brenner; Gerald Friedman; Richard G. Margolese 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

The role of clinical status and therapeutic intervention on natural cell-mediated cytotoxicity in breast cancer was ascertained by monitoring natural killer (NK) cell activity in peripheral blood samples. Patients with localized disease on chemotherapy showed significant reductions in NK activity co